Levothyroxine sodium 0.3 MG Oral Tablet — RxCUI 892255
RxNorm drug concept · Semantic clinical drug
RxCUI 892255
Semantic clinical drug · SCD
● Current RxNorm concept 161 FDA products
393 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI892255
Official nameLevothyroxine sodium 0.3 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevothyroxine sodium 300 MCG Oral Tablet
FDA products mapped161
Package NDCs mapped393
Reported Medicaid activity (SDUD)7,737,089 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Levothyroxine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Your thyroid gland isn't making enough of a hormone called T4, which your whole body depends on to regulate your energy, metabolism, heart rate, and more. Levothyroxine is a precis...
- What exactly is levothyroxine doing for me — why do I need to take it every day?
- Timing really does make a difference with this medication. Food — especially high-fiber foods or anything soy-based — can block your gut from absorbing it properly. Taking it 30 to...
- Why does it matter so much when I take it — can't I just take it with breakfast?
🕸️ Concept Web — How Levothyroxine sodium 0.3 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Levothyroxine sodium 0.3 MG Oral Tablet
RxCUI 892255 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Levothyroxine
10582IN -
Levothyroxine sodium
40144PIN
-
Levothyroxine
-
Brand names 4
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Levo-T
217996BN -
Synthroid
224920BN -
Thyro-Tabs
1189101BN -
Unithroid
284910BN
-
Levo-T
-
Dose forms 25
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Levothyroxine Oral Tablet
372595SCDF -
Levothyroxine sodium Oral Tablet
2649207SCDFP -
Levothyroxine Oral Product
1602753SCDG -
Levothyroxine Pill
1602745SCDG -
Levothyroxine sodium Oral Product
2662680SCDGP -
Levothyroxine sodium Pill
2661467SCDGP -
Levothyroxine Oral Tablet [Levo-T]
367676SBDF -
Levothyroxine Oral Tablet [Synthroid]
368142SBDF - +17 more in this family
-
Levothyroxine Oral Tablet
-
Clinical & branded drugs 9
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Levothyroxine sodium 0.3 MG
892254SCDC -
Levothyroxine sodium 0.3 MG Oral Tablet [Levo-T]
966214SBD -
Levothyroxine sodium 0.3 MG Oral Tablet [Synthroid]
966218SBD -
Levothyroxine sodium 0.3 MG Oral Tablet [Thyro-Tabs]
1189685SBD -
Levothyroxine sodium 0.3 MG Oral Tablet [Unithroid]
966243SBD -
Levothyroxine sodium 0.3 MG [Levo-T]
966366SBDC -
Levothyroxine sodium 0.3 MG [Synthroid]
966370SBDC -
Levothyroxine sodium 0.3 MG [Thyro-Tabs]
1189684SBDC - +1 more in this family
-
Levothyroxine sodium 0.3 MG
Showing up to 8 concepts per family — 22 of 40 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Levothyroxine sodium 0.3 MG
SCDC · 892254 -
Levothyroxine Oral Tablet
SCDF · 372595 -
Levothyroxine sodium Oral Tablet
SCDFP · 2649207 -
Levothyroxine Oral Product
SCDG · 1602753 -
Levothyroxine Pill
SCDG · 1602745 -
Levothyroxine sodium Oral Product
SCDGP · 2662680 -
Levothyroxine sodium Pill
SCDGP · 2661467
Brand-Name Concepts
-
Levothyroxine sodium 0.3 MG Oral Tablet [Synthroid]
SBD · 966218 -
Levothyroxine sodium 0.3 MG Oral Tablet [Unithroid]
SBD · 966243 -
Levothyroxine sodium 0.3 MG Oral Tablet [Levo-T]
SBD · 966214 -
Levothyroxine sodium 0.3 MG Oral Tablet [Thyro-Tabs]
SBD · 1189685 -
Levothyroxine sodium 0.3 MG [Levo-T]
SBDC · 966366 -
Levothyroxine sodium 0.3 MG [Synthroid]
SBDC · 966370 -
Levothyroxine sodium 0.3 MG [Thyro-Tabs]
SBDC · 1189684 -
Levothyroxine sodium 0.3 MG [Unithroid]
SBDC · 966389 -
Levothyroxine Oral Tablet [Levo-T]
SBDF · 367676 -
Levothyroxine Oral Tablet [Synthroid]
SBDF · 368142
📦 FDA Products & Package NDCs
161 products · 393 package NDCs
393 package NDCs map to RxCUI 892255 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 69238-1832-01 | 100 TABLET in 1 BOTTLE, PLASTIC (69238-1832-1) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1832-07 | 1000 TABLET in 1 BOTTLE, PLASTIC (69238-1832-7) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1833-01 | 100 TABLET in 1 BOTTLE, PLASTIC (69238-1833-1) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1833-07 | 1000 TABLET in 1 BOTTLE, PLASTIC (69238-1833-7) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1834-01 | 100 TABLET in 1 BOTTLE, PLASTIC (69238-1834-1) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1834-07 | 1000 TABLET in 1 BOTTLE, PLASTIC (69238-1834-7) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1835-01 | 100 TABLET in 1 BOTTLE, PLASTIC (69238-1835-1) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1835-07 | 1000 TABLET in 1 BOTTLE, PLASTIC (69238-1835-7) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1836-01 | 100 TABLET in 1 BOTTLE, PLASTIC (69238-1836-1) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1836-07 | 1000 TABLET in 1 BOTTLE, PLASTIC (69238-1836-7) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1837-01 | 100 TABLET in 1 BOTTLE, PLASTIC (69238-1837-1) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2007-10-01 |
| 69238-1837-07 | 1000 TABLET in 1 BOTTLE, PLASTIC (69238-1837-7) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2007-10-01 |
| 69238-1838-01 | 100 TABLET in 1 BOTTLE, PLASTIC (69238-1838-1) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1838-07 | 1000 TABLET in 1 BOTTLE, PLASTIC (69238-1838-7) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1839-01 | 100 TABLET in 1 BOTTLE, PLASTIC (69238-1839-1) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1839-07 | 1000 TABLET in 1 BOTTLE, PLASTIC (69238-1839-7) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1840-01 | 100 TABLET in 1 BOTTLE, PLASTIC (69238-1840-1) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1840-07 | 1000 TABLET in 1 BOTTLE, PLASTIC (69238-1840-7) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1841-01 | 100 TABLET in 1 BOTTLE, PLASTIC (69238-1841-1) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 69238-1841-07 | 1000 TABLET in 1 BOTTLE, PLASTIC (69238-1841-7) | Levothyroxine Sodium | Amneal Pharmaceuticals NY LLC | 2003-12-01 |
| 72162-1095-00 | 1000 TABLET in 1 BOTTLE (72162-1095-0) | Levothyroxine Sodium | Bryant Ranch Prepack | 2020-08-03 |
| 72865-0236-10 | 1000 TABLET in 1 BOTTLE (72865-236-10) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0236-90 | 90 TABLET in 1 BOTTLE (72865-236-90) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0237-10 | 1000 TABLET in 1 BOTTLE (72865-237-10) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0237-90 | 90 TABLET in 1 BOTTLE (72865-237-90) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0238-10 | 1000 TABLET in 1 BOTTLE (72865-238-10) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0238-90 | 90 TABLET in 1 BOTTLE (72865-238-90) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0239-10 | 1000 TABLET in 1 BOTTLE (72865-239-10) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0239-90 | 90 TABLET in 1 BOTTLE (72865-239-90) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0240-10 | 1000 TABLET in 1 BOTTLE (72865-240-10) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0240-90 | 90 TABLET in 1 BOTTLE (72865-240-90) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0241-10 | 1000 TABLET in 1 BOTTLE (72865-241-10) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0241-90 | 90 TABLET in 1 BOTTLE (72865-241-90) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0242-10 | 1000 TABLET in 1 BOTTLE (72865-242-10) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0242-90 | 90 TABLET in 1 BOTTLE (72865-242-90) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0243-10 | 1000 TABLET in 1 BOTTLE (72865-243-10) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0243-90 | 90 TABLET in 1 BOTTLE (72865-243-90) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0244-10 | 1000 TABLET in 1 BOTTLE (72865-244-10) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0244-90 | 90 TABLET in 1 BOTTLE (72865-244-90) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0245-10 | 1000 TABLET in 1 BOTTLE (72865-245-10) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0245-90 | 90 TABLET in 1 BOTTLE (72865-245-90) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0246-10 | 1000 TABLET in 1 BOTTLE (72865-246-10) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0246-90 | 90 TABLET in 1 BOTTLE (72865-246-90) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0247-10 | 1000 TABLET in 1 BOTTLE (72865-247-10) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 72865-0247-90 | 90 TABLET in 1 BOTTLE (72865-247-90) | LEVOTHYROXINE SODIUM | XLCare Pharmaceuticals, Inc. | 2023-01-18 |
| 87063-0083-00 | 1000 TABLET in 1 BOTTLE (87063-083-00) | Levothyroxine sodium | ASCLEMED USA INC. | 2026-02-06 |
| 87063-0083-30 | 30 TABLET in 1 BOTTLE (87063-083-30) | Levothyroxine sodium | ASCLEMED USA INC. | 2026-02-06 |
| 87063-0083-60 | 60 TABLET in 1 BOTTLE (87063-083-60) | Levothyroxine sodium | ASCLEMED USA INC. | 2026-02-06 |
| 87063-0083-90 | 90 TABLET in 1 BOTTLE (87063-083-90) | Levothyroxine sodium | ASCLEMED USA INC. | 2026-02-06 |
| 87063-0084-00 | 1000 TABLET in 1 BOTTLE (87063-084-00) | Levothyroxine sodium | ASCLEMED USA INC. | 2026-02-06 |
Observed labelers:
ASCLEMED USA INC. (48) ·
Camber Pharmaceuticals, Inc. (48) ·
AbbVie Inc. (39) ·
Lupin Pharmaceuticals, Inc. (36) ·
Macleods Pharmaceuticals Limited (36) ·
Alvogen, Inc. (24)
· +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.